jejunoileal bypass procedure for morbid obesity (3, 4) and in those with inflammatory bowel disease (IBD) (5) . Because celiac disease is most often recognized in clinically occult or latent stages before marked nutrient depletion develops, hepatic steatosis is probably less frequent than in other intestinal diseases.
At least four patients with adult celiac disease have been described, but they all had massive fatty infiltration of the liver (6) (7) (8) (9) . Presumably lesser degrees of hepatic steatosis also occur. Most often associated with massive steatosis, elevated transaminase and alkaline phosphatase activities have been documented with altered coagulation. However, in each of these four celiac disease patients clinical and biochemical changes related to hepatic steatosis improved with a glutenfree diet. In one patient with massive hepatic steatosis (9), a gluten-free diet administered for about one year resulted in clinical, laboratory and histological improvement in the fatty changes in the liver.
The precise pathogenetic mechanisms involved in deposition of fat within the liver in patients with malabsorption associated with celiac disease require definition. After a jejunoileal bypass, for example, reduced serum levels of some essential and nonessential amino acids are well documented (3, 4) . In addition, changes in serum amino acids have been recorded in patients with kwashiorkor (10, 11) . On the basis of these nutritional disorders, therefore, it has been suggested that malabsorption in celiac disease leads to chronic deficiency of a lipotropic factor (choline); with an associated deficiency of pyridoxine, hepatic steatosis may result (9) . Further studies in celiac disease are needed to define the incidence and mechanisms of development of hepatic steatosis. Chronic hepatitis: In several studies transaminase values were elevated in patients with celiac disease and malabsorption (1, 12, 13) . In a Scandinavian report (12) , 74 consecutive celiac disease patients had liver chemistry tests done; transaminase values were measured in 53 patients, of whom 29 (55%) had elevated levels. In most patients, the transaminase values normalized with a gluten-free diet. Liver biopsies were available in 13 patients and some inflammatory change was documented in 12. In seven of the 12 patients, chronic hepatitis and/or hepatic fibrosis was present, while in the other five less specific or reactive inflammatory changes were evident. In another Scandinavian study (13) , 48 of 132 patients (36%) had elevated transaminases; 37 of the 48 had liver biopsies, and five demonstrated chronic hepatitis. Improved liver chemistry test results after a gluten-free diet were observed in 32 patients, with complete normalization in 24. Finally, in recent study of a consecutive series of 129 patients (1) elevated transaminases were observed in 17 (13%), and all but two patients had normalized transaminase values with a gluten-free diet. One of these patients had antinuclear antibody-positive chronic hepatitis.
Although other causes of abnormal transaminase values should be considered in patients with celiac disease (eg, alcoholic liver disease), other studies have suggested that there might be a link between chronic hepatitis and celiac disease. This is expected because both disorders have been associated with human leukocyte antigen (HLA) B8 and HLA DR3 phenotypes (14, 15) . In a study of 16 patients with chronic hepatitis, Lindberg et al (16) detected changes of untreated celiac disease in three patients (19%). Further assessment of celiac disease patients with abnormal transaminase values, including use of noninvasive tests such as antinuclear antibodies and viral hepatitis screening, may be worthwhile, especially if the abnormal values persist with a gluten-free diet. Unfortunately, the role of more invasive studies, such as liver biopsy, has never been thoroughly evaluated in celiac disease. As a result, the precise frequencies of inflammatory liver disorders, including chronic hepatitis, are unknown. In a recent survey, two of 30 elderly patients (7%) initially diagnosed after age 60 had chronic hepatitis with fibrosis or cirrhosis associated with positive antinuclear antibodies (17) . It would be interesting to define the effects, if any, of a gluten-free diet and drug therapy on hepatic changes in these patients with celiac disease. Gallstones: Several studies have focused on gallbladder function in celiac disease patients. In some patients slow emptying of the gallbladder has been documented (18, 19) , along with impaired contraction response to fat (20) . Studies of enteric endocrine cells from our laboratory demonstrated significant quantitative changes in celiac patients, including a complete absence of mucosal secretin cells in biopsies from untreated celiacs (21) . In addition, studies with test meals in celiac patients have suggested that there may be an impaired secretion of cholecystokinin (22) in celiac disease or possibly impaired gallbladder responsiveness to cholecystokinin (18) .
Despite these changes, there does not appear to be a significant predisposition to gallstones in celiac disease patients. In one review (23), only nine of 350 patients required cholecystectomy for gallstone disease. In a recent survey (17) , six of 30 celiac disease patients initially diagnosed after age 60 had a history of gallstone disease. Hepatic vein obstruction: Although mesenteric vascular ischemia (24) and vasculitis (25) (26) (27) (28) have been observed in celiac disease, recent reports (29-31) of celiac children from North Africa suggested the presence of an associated BuddChiari syndrome, particularly in children from Tunisia and Algeria. Celiac disease and hepatic vein obstruction were later well documented and reported in a subsequent investigation of three adults (32) . Deficiencies in antithrombin III and protein C were noted, and it was hypothesized that malabsorption of vitamin K in celiac disease might result in transient protein C or protein S deficiencies. Genetic and environmental factors in this geographic area need to be explored further. For example, herb consumption and geophagy are apparently common in Algeria, and information on other dietary substances may be important. Sclerosing cholangitis: There are several well documented cases of sclerosing cholangitis associated with celiac disease, some reported as single or multiple cases from separate centres (13, (33) (34) (35) . The clinical, radiological and laboratory chemistry test features of sclerosing cholangitis in patients with celiac disease did not appear to differ from the features recorded for primary sclerosing cholangitis occurring in the absence of celiac disease or in the presence of other associated gastrointestinal disorders such as IBD. In our report (34) , however, histopathological changes of lymphocytic cholangitis were emphasized due to the predominant lymphocytic infiltrate in biliary ductal epithelium, reminiscent of the epithelial lymphocytosis in both of the 'newly described' entities: lymphocytic gastritis and lymphocytic colitis associated with celiac disease (36, 37) .
Several recent studies have suggested that genetic and immunological factors may be important in the pathogenesis of sclerosing cholangitis (38) (39) (40) . Immune complexes may be formed with a common antigenic basis, resulting in tissue damage.
To date, however, no specific antigen has been detected. Alternatively, diminished suppressor T cell function may permit effector cytotoxic lymphocytes to alter a modifying antigen, ie, gliadin. These effector cells may then recognize and attack a patient's histocompatibility antigens. Interestingly, the frequency of the HLA B8 and DR3 phenotype is increased in sclerosing cholangitis patients compared with control subjects (41, 42) , and in families with both sclerosing cholangitis and IBD (43) . These antigens may be present in high concentrations in both biliary and intestinal epithelial cells. Further immunological and genetic studies are required to explore this intriguing relationship between celiac disease and sclerosing cholangitis. Primary biliary cirrhosis: Since 1978 there have been over 20 patients described with both celiac disease and primary biliary cirrhosis (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) (54) (55) (56) (57) . Most of these patients were female. Most patients also have positive antimitochondrial antibody tests, but occasionally these may be negative (49) , and some have demonstrated HLA-B8. In some, other 'autoimmune' disorders have been recorded, including dermatitis herpetiformis, renal tubular acidosis, Sjögren's syndrome and arthritis. Since both disorders tend to occur commonly in middleaged females, their concomitant detection in a single patient is not surprising. In contrast, celiac disease patients over age 60 only very rarely (44, 47, 49) develop primary biliary cirrhosis; this may reflect, in part, a reduced life expectancy due to the cirrhosis.
Patients with both diseases may share many common clinical features. Weight loss, malabsorption, bone disease, steatorrhea and elevated alkaline phosphatase activities are frequent in both celiac disease and primary biliary cirrhosis. Thus, at an early stage of their coexistence, celiac disease or primary biliary cirrhosis may not be readily recognized. In all patients reported with both disorders, regardless of geographical origin or race, restriction of dietary gluten caused cessation of diarrhea, weight gain or both, but abnormal liver chemistry tests were not improved despite a gluten-free diet. Hepatic malignancies: Although hepatocellular carcinoma has been described in one patient, cirrhosis was also present (58) . Occasionally the liver may be involved with lymphoma, the most frequently detected malignant disorder in celiac disease patients (59) . In some patients, lymphomatous deposits have been detected in the liver, presumably as metastatic lesions (58) . In one report, for example, lymphoma was apparently secondary to jejunal lymphoma, complicating celiac disease (58) . In general, hepatic involvement in celiac patients with lymphoma is limited and overshadowed by the clinical course of the intestinal disease. In a recent report (60) , a fulminant cholestatic syndrome developed in a celiac disease patient, resulting in hepatic failure. Later investigations revealed widespread hepatic involvement with an unusual lymphoid neoplasm classified as a hepatosplenic lymphoma, a rare type of peripheral T cell lymphoma with rearrangement of the gamma-delta T cell receptor (61, 62) .
CHRONIC PANCREATIC DISEASES
Although celiac disease has been associated with diabetes, the coexistence of advanced pancreatic exocrine insufficiency and celiac disease has been recorded only occasionally (63) (64) (65) (66) (67) (68) (69) (70) . Pancreatic calcification is most often associated with chronic or persisting pancreatic inflammation which, in North America, is usually due to excessive consumption of alcoholic beverages. Atrophy, fibrosis and altered pancreatic function have been observed in experimental animals treated with diets deficient in protein (71) , in adults with protein-energy malnutrition (72) , in children with kwashiorkor (73, 74) and in some early autopsy studies of patients with celiac disease (75) . In addition, pancreatic calcification has been reported with chronic protein malnutrition in the Indian subcontinent and in some African countries (71) . Finally, a patient with celiac disease and tropical calcific pancreatitis has recently been described (76) .
Although the precise frequency of pancreatic disease in patients with celiac disease is unknown, impaired pancreatic function must occur more often than is appreciated. For example, it was estimated that over 20% of children with celiac disease may have defective exocrine pancreatic function (77) , which may be due to a number of factors. Impaired elaboration and/or release of pancreatic stimulating hormones from the diseased proximal small intestine may result (22) . This has been associated with immunocytochemical evidence of alterations in enteric endocrine cells; in particular, secretin cells were noted to be absent from biopsies of untreated celiac disease patients (21) . Studies with test meals in celiac patients have also suggested impaired secretion of cholecystokinin-pancreozymin, which results in impaired pancreatic exocrine cell stimulation (78) . In addition, a deficiency of amino acids may result in part from impaired uptake of amino acids in the small intestine, leading to a reduction in precursor materials for pancreatic enzyme synthesis (11, 66) . Finally, protein malnutrition may lead to pancreatic structural changes, including acinar cell atrophy and pancreatic fibrosis (11, 75) , leading to impaired pancreatic exocrine function.
FUTURE CONSIDERATIONS
Recognition of hepatobiliary tract and pancreatic diseases in patients with celiac disease is increasing. Unsuspected or clinically occult celiac disease is also being detected in this Hepatobiliary and pancreatic disorders in celiac disease setting. In the future, screening of large population groups with idiopathic or cryptogenic chronic liver diseases, for example, may be particularly productive in further delineation of this intriguing co-relationship and improve detection of occult or latent celiac disease. In a recent Swedish study (79) , a microenzyme-lined immunosorbent assay for gliadin antibodies was used to examine the sera of 327 consecutive patients with chronic liver disease. In 19 patients (6%) positive tests were detected and, in most, a small intestinal biopsy confirmed the presence of previously undiagnosed celiac disease. Interestingly, the liver disorder was previously considered 'cryptogenic' in most of the patients before detection of celiac disease. It remains to be determined whether earlier detection and gluten-free diet treatment has a beneficial effect on hepatic function.
